Skip to main content
Broncus Holding Corporation logo

Broncus Holding Corporation — Investor Relations & Filings

Ticker · 2216 HKEX Manufacturing
Open in API
Filings indexed 194 across all filing types
Latest filing 2025-03-05 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2216

About Broncus Holding Corporation

http://www.broncus.com

Broncus Holding Corporation is a medical device company focused on the research, development, manufacturing, and commercialization of innovative solutions for lung diseases. The company is recognized as a pioneer in the field of interventional pulmonology. Broncus provides comprehensive solutions across the spectrum of lung care, including advanced diagnostic solutions, lung cancer treatment solutions, and specialized solutions for chronic obstructive pulmonary disease (COPD). Its product portfolio consists of medical devices and consumables designed to improve patient outcomes in global markets, including Mainland China and the European Union.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2025
Regulatory Filings Classification · 1% confidence The document is a Hong Kong Exchange (HKEX) Monthly Return under Chapter 19B of the Listing Rules, detailing movements in authorised share capital, issued and treasury shares, share options, RSUs, and share repurchases for the month ended 28 February 2025. It is a periodic regulatory submission on securities movements rather than a full financial report (e.g., 10-K/IR), earnings release, proxy statement, management change, or investor presentation. It does not fit specialized categories like share issue only (SHA) because it covers multiple securities actions in one regulatory return. Therefore, it falls into the general Regulatory Filings category (RNS).
2025-03-05 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return filed pursuant to the Hong Kong Stock Exchange listing rules, detailing the company’s own share transactions (repurchase of ordinary shares held as treasury shares, on‐market sale, repurchase prices, aggregate consideration, etc.). This is not a general regulatory announcement or summary but the full repurchase/treasury shares report. Such filings fall under Transaction in Own Shares (POS).
2025-02-27 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a regulatory “Next Day Disclosure Return” (FF305) filed under HKEX rules, detailing changes in issued and treasury shares and reporting on-market share repurchases (Sections I & II) and treasury share transactions. It is a mandatory disclosure of the company’s own share buybacks, fitting the “Transaction in Own Shares” category rather than an earnings, AGM, or funding update. Therefore, it is classified as POS (Transaction in Own Shares).
2025-02-25 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is Hong Kong Stock Exchange Form FF305 (“Next Day Disclosure Return”) disclosing changes in issued and treasury shares, specifically detailing share repurchases (on-market buybacks) under HKSE Main Board/GEM Rules. This is a mandatory regulatory filing reporting transactions in its own shares. It is not an earnings release, annual report, or management announcement but a detailed repurchase report. According to our taxonomy, this is a “Transaction in Own Shares.”
2025-02-20 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return (form FF305) under the Rules Governing the Listing of Securities on the Hong Kong Stock Exchange. It details share repurchases, changes in issued and treasury shares, repurchase prices, and compliance with exchange rules. This is a direct report of the company buying back its own shares (a share repurchase), fitting the “Transaction in Own Shares” category (Code: POS).
2025-02-18 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return filed under the Hong Kong Stock Exchange Main Board/GEM rules, detailing changes in issued shares and treasury shares, specifically reporting on a share repurchase (on-market share buyback) and the resulting closing balances. It is not an AGM presentation, annual or interim report, nor a simple announcement; rather it is the formal transaction report of the company’s own share repurchases. This corresponds directly to the “Transaction in Own Shares” category (Code: POS).
2025-02-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.